Peritoneal Cancer Index Dominates Prognosis After CRS–HIPEC for Colorectal Peritoneal Metastases: A Consecutive Single-Centre Cohort with 3-Year Follow-Up
In this real-world cohort, PCI was the only independent predictor of 3-year survival after CRS + HIPEC for CPM; neither CCR status, surgical extent, nor HIPEC agent altered prognosis once PCI was considered. PCI should therefore remain the principal selection criterion while molecular and biological markers are integrated into future risk models.
Authors
- Paweł Lesiak (ORCID: https://orcid.org/0009-0008-6454-4943)
- Michał Kazanowski (ORCID: https://orcid.org/0009-0008-8080-3001)
- T Jastrzebski (ORCID: https://orcid.org/0000-0002-8266-8826)
- Marcin Pawłowski (ORCID: https://orcid.org/0000-0002-8906-2309)
- Paweł Maciejewski (ORCID: https://orcid.org/0000-0001-9694-1072)
- Marek Bębenek (ORCID: https://orcid.org/0000-0001-7376-7286)
- Bartosz Kapturkiewicz (ORCID: https://orcid.org/0000-0002-2894-4834)
- Jędrzej Wierzbicki (ORCID: https://orcid.org/0000-0001-9959-8855)
Institutions
- Wrocław University of Science and Technology (PL)
- Lublin Oncology Center (PL)
- Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL)
- Razi Hospital (IR)
- AGH University of Krakow (PL)
- Gdańsk Medical University (PL)
- Polish Academy of Sciences (PL)
Publication Details
- Journal
- Cancers
- Published
- 2025-11-10
- DOI
- https://doi.org/10.3390/cancers17223614
- Citations
- 1
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 2.01